These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 30220488

  • 1. [Interferon gamma release assay tests and nontuberculous mycobacteria].
    Andréjak C, Barras E.
    Rev Mal Respir; 2018 Oct; 35(8):900-901. PubMed ID: 30220488
    [No Abstract] [Full Text] [Related]

  • 2. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
    Saleem N, Saba R, Maddika S, Weinstein M.
    Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical importance of Mycobacterium kansasii and evaluation of the need to identify nontuberculous mycobacteria].
    Etxebarrieta M, Rodrigo A, Martín C, Ojer M, Ruz A, Dorronsoro I.
    Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):113-6. PubMed ID: 11904083
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Reply to the article: "Clinical significance of Mycobacterium kansasii isolation and assessment of the need for identifying non-tuberculous mycobacteria"].
    Casal-Román M.
    Enferm Infecc Microbiol Clin; 2002 Nov; 20(9):475; author reply 475-6. PubMed ID: 12425883
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mycobacterium kansasii.
    Johnston JC, Chiang L, Elwood K.
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of reformulated chemiluminescent DNA probe (AccuProbe) for culture identification of Mycobacterium kansasii.
    Tortoli E, Simonetti MT, Lavinia F.
    J Clin Microbiol; 1996 Nov; 34(11):2838-40. PubMed ID: 8897195
    [Abstract] [Full Text] [Related]

  • 18. Sweet's syndrome associated with Mycobacterium kansasii infection in an immunocompetent woman.
    Juan CK, Shen JL, Yang CS, Liu KL, Yen CY.
    J Dtsch Dermatol Ges; 2015 Sep; 13(9):921-3. PubMed ID: 26086480
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.
    Yuste JR, Bertó J, Del Pozo JL, Leiva J.
    J Antimicrob Chemother; 2017 Feb; 72(2):625-628. PubMed ID: 27999019
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.